Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated to version v2.11.2, with new additions from late September and early October, while the previous version v2.11.0 and several older entries have been removed.
    Difference
    0.5%
    Check dated 2024-10-03T04:50:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has added a plan to make IPD and related data dictionaries available, along with sharing large scale genomic sequencing data with dbGaP subscribers, while also noting the resolution of delays in displaying study record information.
    Difference
    1%
    Check dated 2024-09-25T22:28:26.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.7%
    Check dated 2024-09-18T16:35:57.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T04:23:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T22:40:43.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.
    Difference
    0.3%
    Check dated 2024-07-23T14:21:03.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.